AmyDys Inc.
Clinical trials sponsored by AmyDys Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Eye injection could spot hidden brain bleeding risk Results expected Dec 2026 (estimated)
- Eye scan could spot Alzheimer's without brain scans Results expected Jul 2027 (estimated)
-
Eye scan could spot Alzheimer's without brain scans
Diagnosis Recruiting nowThis study tests a single injection of AMDX-2011P, a dye that may stick to Alzheimer's-related plaques in the retina. Researchers want to see if it is safe and can detect these plaques using eye imaging. 25 adults with confirmed Alzheimer's will participate. If successful, this c…
Phase 2 • Sponsor: Amydis Inc. • Aim: Diagnosis
Last updated Sep 02, 2026 00:00 UTC
-
Eye injection could spot hidden brain bleeding risk
Diagnosis Recruiting nowThis study tests a dye called AMDX-2011P that is injected into the vein to see if it can light up amyloid deposits in the retina, which may indicate cerebral amyloid angiopathy (CAA), a condition that raises the risk of brain bleeding. About 25 adults with CAA will receive a sing…
Phase 2 • Sponsor: Amydis Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC